Mark A. Glickman - Mar 23, 2022 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Chief Business Officer
Signature
/s/ Mark A. Glickman
Stock symbol
TXMD
Transactions as of
Mar 23, 2022
Transactions value $
$0
Form type
4
Date filed
3/28/2022, 07:00 AM
Previous filing
Oct 15, 2021
Next filing
Mar 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Award $0 +260K $0.00 260K Mar 23, 2022 Common Stock 260K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.